These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18212250)
1. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation. Li JG; Haines DS; Liu-Chen LY Mol Pharmacol; 2008 Apr; 73(4):1319-30. PubMed ID: 18212250 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Li J; Li JG; Chen C; Zhang F; Liu-Chen LY Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208 [TBL] [Abstract][Full Text] [Related]
3. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation. Zhang F; Li J; Li JG; Liu-Chen LY J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation. Li JG; Benovic JL; Liu-Chen LY Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. Li JG; Zhang F; Jin XL; Liu-Chen LY J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694 [TBL] [Abstract][Full Text] [Related]
6. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034 [TBL] [Abstract][Full Text] [Related]
7. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Li JG; Chen C; Liu-Chen LY Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303 [TBL] [Abstract][Full Text] [Related]
8. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. Li JG; Chen C; Liu-Chen LY J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation. Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376 [TBL] [Abstract][Full Text] [Related]
10. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor. Chen C; Li JG; Chen Y; Huang P; Wang Y; Liu-Chen LY J Biol Chem; 2006 Mar; 281(12):7983-93. PubMed ID: 16431922 [TBL] [Abstract][Full Text] [Related]
11. Localization of the kappa opioid receptor in lipid rafts. Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160 [TBL] [Abstract][Full Text] [Related]
12. kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins. Huang P; Steplock D; Weinman EJ; Hall RA; Ding Z; Li J; Wang Y; Liu-Chen LY J Biol Chem; 2004 Jun; 279(24):25002-9. PubMed ID: 15070904 [TBL] [Abstract][Full Text] [Related]
13. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991 [TBL] [Abstract][Full Text] [Related]
14. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization. Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353 [TBL] [Abstract][Full Text] [Related]
15. Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. Chen Y; Chen C; Wang Y; Liu-Chen LY J Pharmacol Exp Ther; 2006 Nov; 319(2):765-75. PubMed ID: 16882876 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745 [TBL] [Abstract][Full Text] [Related]
18. Differential agonist regulation of the human kappa-opioid receptor. Blake AD; Bot G; Li S; Freeman JC; Reisine T J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509 [TBL] [Abstract][Full Text] [Related]
19. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
20. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway. Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y Cells; 2021 Oct; 10(10):. PubMed ID: 34685631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]